If, as we show here, low concentrations of decitabine are sufficient to completely deplete MLL‐rearranged ALL cells from functional DNMT1, higher concentrations of decitabine should not provide any additional effects, other than aspecific drug effects that are not related to DNA demethylation. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.